EOCN NASDAQ
Eocene Ltd.
1W: -0.6%
1M: -12.4%
YTD: -12.4%
$3.61
+0.20 (+6.02%)
Weekly Expected Move ±14.3%
$3
$3
$4
$4
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.8M
52W Range3.12-13.2
Volume4,850
Avg Volume47,411
Beta0.66
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAllen J. Baharaff
Employees6
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2026-09-10
Websitegalmedpharma.com
16 Abba Hillel Road
Ramat Gan, TA 5250608
IL
Ramat Gan, TA 5250608
IL
About Eocene Ltd.
Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Latest News
No recent news
Recent Insider Trades
No insider trades found